United Imaging Receives Contract from Vizient for its X-ray and Magnetic Resonance Imaging Systems

United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, has received a contract from Vizient, Inc., for its entire portfolio of DR (X-Ray) and MR (magnetic resonance) systems.

United Imaging notes the contract expands the number of modalities offered through Vizient by United Imaging, which last year also received a contract for its suite of cutting-edge CT (computed tomography) equipment.

Vizient is the largest member-driven health care performance improvement company in the country with a diverse membership base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents more than $110 billion in annual purchasing volume.

United Imaging takes a highly vertically integrated approach to innovation to help manage both quality and costs and enable the most cutting-edge technology across all its modalities. In addition, the company’s bold approach to the U.S. market includes several unique aspects.

All-in ConfigurationsTM means that its systems are sold fully loaded with all available features included from the outset, giving customers the flexibility to immediately or in the future provide advanced offerings to patients without additional upgrade costs. Software Upgrades for Life TM refers to the company’s groundbreaking commitment to provide the latest software upgrades throughout the product lifecycle across its entire installed base at no additional cost to the healthcare provider, helping them provide the highest standards of care.

United Imaging also offers a United Performance Guarantee on all full-service agreements, flexible coverage options for in-house biomedical engineer organizations, and customized financing solutions to streamline buying and owning medical equipment.

“We are excited to receive another contract with Vizient,” said Jeffrey M. Bundy, Ph.D, CEO of United Imaging Healthcare Solutions. “Through this contract, we hope to help more healthcare organizations improve the quality of their patient care.”

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.